Trial Profile
A trial of VAL 083 in patients with solid tumors
Status:
Planning
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs Dianhydrogalactitol (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Del Mar Pharmaceuticals
- 01 Oct 2015 New trial record